SEC Company Response from DarioHealth Corp. (DRIO) (CIK 0001533998) (DRIO) — Mar 23, 2017
DarioHealth Corp. (DRIO) (CIK 0001533998)
Date: March 23, 2017 · CIK: 0001533998 · Accession: 0001144204-17-016281
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-216607
Letter
Via EDGAR Securities and Exchange Commission Division of Corporation Finance Re: DarioHealth Corp. Registration Statement on Form S-3 Filed March 10, 2017 File No. 333-216607
Dear Ms. Ravitz:
The purpose of this letter is to respond to your letter of March 15, 2017 regarding the above-referenced registration statement. We are concurrently filing via EDGAR Amendment No. 1 to the Form S-3 to present updated financial statements.
* * *
We appreciate your letter. Please call our attorney, Robert Condon, (212) 660-3049, of Zysman, Aharoni, Gayer and Sullivan & Worcester LLP, if you have any questions or require additional information.
Sincerely,
DarioHealth Corp.
Show Raw Text
CORRESP
1
filename1.htm
DARIOHEALTH CORP.
9 Halamish Street
Caesarea Industrial Park
3088900, Israel
March 23, 2017
Via EDGAR
Amanda Ravitz, Assistant Director
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, DC 20549
Re: DarioHealth Corp.
Registration
Statement on Form S-3
Filed
March 10, 2017
File
No. 333-216607
Dear Ms. Ravitz:
The purpose of this letter is to respond
to your letter of March 15, 2017 regarding the above-referenced registration statement. We are concurrently filing via EDGAR Amendment
No. 1 to the Form S-3 to present updated financial statements.
* * *
We appreciate your letter. Please call
our attorney, Robert Condon, (212) 660-3049, of Zysman, Aharoni, Gayer and Sullivan & Worcester LLP, if you have any questions
or require additional information.
Sincerely,
DarioHealth Corp.
By: /s/ Zvi Ben David
Name: Zvi Ben David
Title: Chief Financial Officer
cc, with a marked copy of Amendment No. 1: Caleb French